Beta Bionics Inc.
Beta Bionics Inc. (BBNX): 4 pipeline candidates · ~26 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
25.9 months
D/E 0.12 · 0% dilution
Lead: Approved
4 candidates
N/A
0 buys · 20 sells (180d)
A transparent, data-derived signal for Beta Bionics Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$594.9M
Cash
$30.3M
Quarterly Burn
$23.8M
Runway
25.9 mo
Revenue
$27.6M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| bihormonal ilet | Preclinical |
| ilet bionic pancreas | Approved |
| mint | Preclinical |
| patch pump | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
127
Total value held
$394.9M
| Holder | Shares | Value |
|---|---|---|
| eventide asset management, llc | 5,945,488 | $59.6M |
| morgan stanley | 4,227,634 | $42.4M |
| farallon capital management llc | 3,607,920 | $36.2M |
| vanguard capital management llc | 3,455,954 | $34.6M |
| blackrock, inc. | 3,038,595 | $30.4M |
| rtw investments, lp | 2,000,000 | $20.0M |
| perceptive advisors llc | 1,685,888 | $16.9M |
| eversept partners, lp | 1,414,838 | $14.2M |
| deerfield management company, l.p. | 1,324,000 | $13.3M |
| omega fund management, llc | 1,316,183 | $13.2M |
Showing top 10 of 127 institutional holders of Beta Bionics Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Beta Bionics Inc.'s pipeline?
Beta Bionics Inc. (BBNX) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Beta Bionics Inc.'s lead drug candidate?
Beta Bionics Inc.'s most advanced tracked candidate is bihormonal ilet (Preclinical) for Type 1 diabetes (T1D).
What is Beta Bionics Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Beta Bionics Inc. has approximately 25.9 months of cash runway.
What is Beta Bionics Inc.'s market capitalization?
Beta Bionics Inc.'s market capitalization is approximately $594.9M.
Who is the CEO of Beta Bionics Inc.?
Mr. Sean T. Saint PE is the chief executive officer of Beta Bionics Inc. (BBNX).
Get the full picture on Beta Bionics Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.